Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Neoplasms × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 253 Rectal Neoplasms 154 Colonic Neoplasms 127 Stomach Neoplasms 99 Pancreatic Neoplasms 93 Breast Neoplasms 77 Esophageal Neoplasms 76 Neoplasm Metastasis 58 Squamous Cell Carcinoma of Head and Neck 56 Head and Neck Neoplasms 56 Neoplasms 43 Adenocarcinoma Of Esophagus 37 Esophageal Squamous Cell Carcinoma 27 Adenocarcinoma 24 Unspecified Adult Solid Tumor, Protocol Specific 15 Carcinoma, Hepatocellular 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Anus Neoplasms 12 Keratosis, Actinic 11 Gastrointestinal Neoplasms 11 Biliary Tract Neoplasms 11 Gallbladder Neoplasms 10 Carcinoma, Squamous Cell 10 Urinary Bladder Neoplasms 9 Nasopharyngeal Carcinoma 9 Liver Neoplasms 9 Cholangiocarcinoma 9 Carcinoma 9 Bile Duct Neoplasms 9 Recurrence 8

Interventions

pembrolizumab 2 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2026-04-08

iintune-1

Takeda

Phase 1/2 Completed

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡